Loading provider…
Loading provider…
Cardiovascular Disease Physician in Los Angeles, CA
NPI: 1114969680Primary Practice Location
RONALD REAGAN UCLA MEDICAL CENTER
757 Westwood Plz, Los Angeles, CA
Primary Employer
UCLA Medical Plaza
uclahealth.org
HQ Phone
Get MD Priscilla's Phone Numberphone_androidMobile
Get MD Priscilla's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
1998 - 2026
CA State Medical License

American Board of Internal Medicine
Cardiovascular Disease
UCSF School of Medicine
medschool.ucsf.edu
Fellowship • Cardiovascular Disease
1999 - 2002
Medical School
Until 1996
Residency • Internal Medicine
1996 - 1999
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 93306Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | 70 | 71 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 47 | 59 |
| 3 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 32 | 76 |
| 4 | 93010Routine electrocardiogram (EKG) using at least 12 leads with interpretation and report | 21 | 23 |
| 5 | 99239Hospital discharge day management, more than 30 minutes | 18 | 18 |
Endothelial dysfunction in coronary heart disease is more than a systemic process.
PCSK9 Inhibition to Lower LDL-Cholesterol and Reduce Cardiovascular Risk Great Expectations
Authors: David Waters
Journal: Circ Res
HIV Infection and the Risk of World Health Organization-Defined Sudden Cardiac Death.
Lead Sponsor: Vanderbilt University Medical Center
Collaborators: Emory University, University of California, San Francisco, University of Minnesota, Vanderbilt University, Yale University
Intervention / Treatment: DRUG: Placebo, DRUG: Baricitinib 4 MG
Lead Sponsor: Priscilla Hsue, MD
Collaborators: University of California, Los Angeles, University of Utah
Intervention / Treatment: DRUG: Placebo, DRUG: VB-201
Lead Sponsor: Priscilla Hsue, MD
Collaborators: Vitalant Research Institute, San Francisco General Hospital
Intervention / Treatment: BIOLOGICAL: Placebo, BIOLOGICAL: COVID-19 Convalescent Plasma (CCP)